Ubs Group Ag Medicinova Inc Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
A detailed history of Ubs Group Ag transactions in Medicinova Inc stock. As of the latest transaction made, Ubs Group Ag holds 149 shares of MNOV stock, worth $312. This represents 0.0% of its overall portfolio holdings.
Number of Shares
149
Previous 2,512
94.07%
Holding current value
$312
Previous $3,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding MNOV
# of Institutions
34Shares Held
4.69MCall Options Held
7.2KPut Options Held
3.8K-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$2.32 Million0.52% of portfolio
-
Black Rock Inc. New York, NY695KShares$1.46 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA623KShares$1.31 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA459KShares$963,4060.0% of portfolio
-
Citigroup Inc448KShares$940,7090.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $103M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...